FDA — authorised 11 June 2020
- Marketing authorisation holder: VIELA BIO
- Status: approved
🇺🇸 Uplizna in United States
FDA authorised Uplizna on 11 June 2020
Marketing authorisations
FDA — authorised 11 June 2020
- Application: BLA761142
- Marketing authorisation holder: VIELA BIO
- Local brand name: UPLIZNA
- Indication: INJECTABLE — INJECTION
- Status: approved
Uplizna in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Uplizna approved in United States?
Yes. FDA authorised it on 11 June 2020; FDA authorised it on 11 June 2020.
Who is the marketing authorisation holder for Uplizna in United States?
VIELA BIO holds the US marketing authorisation.